<DOC>
	<DOCNO>NCT00474253</DOCNO>
	<brief_summary>The purpose trial demonstrate faster recovery neuromuscular block induce 1.2 mg/kg ZemuronÂ® reversal 3 minute 16.0 mg/kg Org 25969 compare recovery neuromuscular block induce 1.0 mg/kg succinylcholine .</brief_summary>
	<brief_title>Comparison Recovery From Rocuronium 1.2 mg/kg Followed By Org 25969 16 mg/kg 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg ( 19.4.303 ) ( P05946 )</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>ASA Class 1 2 ; 18 65 year age ( inclusive ) ; Scheduled elective surgical procedure general anesthesia require short duration neuromuscular block use rocuronium succinylcholine require endotracheal intubation ; Scheduled surgery supine position ; Body mass index ( BMI ) &lt; 30 ; Given write informed consent . Subjects ischemic heart disease history myocardial infarction within last year ; Subjects difficult intubation expect due anatomical malformation ; Subjects know suspect neuromuscular disorder impair neuromuscular blockade and/or significant renal dysfunction ; Subjects know suspect ( family ) history malignant hyperthermia ; Subjects know suspect allergy narcotic , muscle relaxant , midazolam , anesthetic medication use surgery ; Subjects receive medication know interfere neuromuscular block agent anticonvulsant , antibiotic Mg2+ ; Subjects use neostigmine and/or glycopyrrolate may contraindicate ; Female subject pregnant breastfeeding ; Females subject childbearing potential use acceptable method birth control [ condom diaphragm spermicide , vasectomized partner ( &gt; 6 month ) , IUD , abstinence ] ; Subjects already participate Org 25969 trial include Protocol 19.4.303 ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>